COMPANY:

Seasun Biomaterials

"Seonbiomaterials...announced on the 11th that it will participate in the Indian government's national project to analyze molecular markers for colorectal cancer genetic diagnosis. The project, in which Seonbio is participating, is supported by the Indian Council Medical Research (ICMR)...Seonbio will supply its self-developed MSI diagnostic product (U-TOP MSI detection kit) for this project."

"Sisun Biomaterials...announced that it will be joining hands with Ainocle...to collaborate on the development of a precision medical system...Through this agreement, the two companies plan to join forces to develop and build a precision medical system based on multi-omics and, based on this, maximize the potential for application in the medical field."

"The genome-based molecular diagnostic company 'Seasoon Biomaterials' recently announced that it is actively developing an innovative cancer diagnosis technology using the genome methylation panel (MPP Panel)...We are continuously conducting research and development for commercialization and clinical application of cancer diagnosis technology through methylation panels, and we are doing our best to provide better diagnosis and treatment to patients..."

"Seesun Biomaterials...announced...that its 'U-TOP MSI detection kit', which evaluates microsatellite instability (MSI), which is essential for predicting the efficacy of immunotherapy anticancer drugs, will be exported to Georgia...The company has agreed to supply this diagnostic kit to Georgia (Europe) Company L for three years until the first half of 2027."

"Seasun Biomaterials announced on the 5th that it will be participating in the World Conference on Lung Cancer (WCLC) to be held in San Diego, USA from the 7th to the 10th and presenting the prospective clinical results of the 'Epi-TOP LUNG assay' for early diagnosis of lung cancer."